查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1608064

免疫檢測分析儀市場：按產品和應用分類－2025年至2030年全球預測

Immunoassay Analyzers Market by Product (Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay), Application (Autoimmune Disease, Cardiology, Endocrinology) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年免疫檢測分析儀市值為121.5億美元，預計到2024年將達到127.2億美元，複合年成長率為6.92%，到2030年將達到194.3億美元。

生物標記物的準確檢測和定量對於使用免疫檢測分析儀進行生物醫學研究和診斷測試至關重要。該市場包括按類型、應用和最終用戶（例如醫院、實驗室和診斷中心）細分的自動分析儀和手動分析儀。這些分析儀對於個人化醫療中的疾病管理、治療監測和診斷至關重要。慢性病的增加、人口老化和生物技術的進步是市場成長的主要驅動力。對個人化醫療的需求不斷成長以及免疫檢測技術的進步也將推動市場的發展。一個關鍵的商業機會是將人工智慧和機器學習整合到這些分析設備中，以提高其預測分析能力和開拓，並進入由消費者對更容易獲得的醫療保健解決方案的需求驅動的快速成長的家庭測試市場。然而，市場面臨先進免疫檢測分析儀的高成本和複雜的法規環境等挑戰，這些挑戰正在減緩市場滲透和技術採用。此外，在發展中地區，對專業操作技能的需求可能是一個障礙。為了克服這些問題，注重成本效益、使用者友好的儀器和強大的分析技術的創新至關重要。公司應進一步開發低成本生物感測器和可攜式免疫檢測設備，以適應日益必要的就地檢驗。從研究的角度來看，探索整合奈米技術和微流體的下一代免疫測量平台有望提高靈敏度和準確性。此外，與生物技術公司的策略聯盟和合作可實現快速技術整合和市場擴張。市場競爭激烈且不斷發展，對創新的需求強勁，以滿足醫療保健環境的多樣化需求。因此，專注於技術突破和適應策略可以開拓重要的市場佔有率和業務成長。

主要市場統計
基準年[2023] 121.5億美元
預測年份 [2024] 127.2億美元
預測年份 [2030] 194.3億美元
複合年成長率（%） 6.92%

市場動態：揭示快速發展的免疫檢測分析儀市場的關鍵市場洞察

供需的動態交互作用正在改變免疫檢測分析儀市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 癌症領域對免疫測量的高需求
    • 基於免疫測量的就地檢驗和快速檢測日益普及
    • 要求進行藥物和酒精測試的嚴格規定
  • 市場限制因素
    • 不利的贖回措施
    • 嚴格的核准規定
  • 市場機會
    • 持續開發用於診斷微生物感染疾病的免疫檢測分析儀
    • 融合先進技術，改良產品
  • 市場問題
    • 免疫檢測分析儀誤讀

波特五力：駕馭免疫檢測分析儀市場的策略工具

波特的五力框架是了解免疫檢測分析儀市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解免疫檢測分析儀市場的外部影響

外部宏觀環境因素在塑造免疫檢測分析儀市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析：了解免疫檢測分析儀市場的競爭格局

對免疫檢測分析儀市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：免疫檢測分析儀市場供應商的績效評估

FPNV定位矩陣是評估免疫檢測分析儀市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：規劃免疫檢測分析儀市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，免疫檢測分析儀市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 腫瘤學中對免疫檢測的使用有很高的需求
      • 增加就地檢驗和快速免疫檢測檢測的採用
      • 要求進行藥物和酒精測試的嚴格規定
    • 抑制因素
      • 不利的退款政策
      • 嚴格的核准規定
    • 機會
      • 持續開發用於診斷微生物感染疾病的免疫檢測分析儀
      • 融合先進技術，改良產品
    • 任務
      • 免疫檢測分析儀讀數不正確
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章免疫檢測分析儀市場：依產品

  • 介紹
  • 化學冷光免疫檢測
  • 耗材及配件
  • 酵素免疫分析法
  • 螢光分析儀
  • 免疫檢測

第7章免疫檢測分析儀市場：依應用分類

  • 介紹
  • 自體免疫疾病
  • 心臟病學
  • 內分泌學
  • 傳染病檢查
  • 腫瘤學
  • 治療監測

第 8 章：美洲免疫檢測分析儀市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太免疫檢測分析儀市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東和非洲免疫檢測分析儀市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • Boditech Med Inc.
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Merck KGaA
  • Ortho-Clinical Diagnostics, Inc.
  • Quidel Corporation
  • Siemens Healthineers AG
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • WAK-Chemie Medical GmbH
Product Code: MRR-ED54C46E890E

The Immunoassay Analyzers Market was valued at USD 12.15 billion in 2023, expected to reach USD 12.72 billion in 2024, and is projected to grow at a CAGR of 6.92%, to USD 19.43 billion by 2030.

Immunoassay analyzers are crucial in biomedical research and diagnostic testing, offering precise detection and quantification of biological markers. The scope of this market includes automated and manual analyzers segmented by type, application, and end-user, such as hospitals, research labs, and diagnostic centers. These analyzers are pivotal for diagnostics in disease management, therapeutic drug monitoring, and personalized medicine. The growing prevalence of chronic diseases, an aging population, and advances in biotechnology are significant drivers for market growth. Increasing demand for personalized medicine and advancements in immunoassay technology also propel the market. Key opportunities emerge with the integration of AI and machine learning in these analyzers, enhancing predictive analytics capabilities and efficiency, as well as tapping into the burgeoning home testing market driven by consumer demands for more accessible healthcare solutions. However, the market faces challenges such as high costs of advanced immunoassay analyzers and complex regulatory environments, which can slow down market penetration and technology adoption. Additionally, the need for specialized operating skills can be a barrier in developing regions. To overcome these, innovations focusing on cost-effective, user-friendly devices, and robust analytical technologies are crucial. Companies should further explore developing low-cost biosensors and portable immunoassay devices suitable for point-of-care testing, which is increasingly becoming a necessity. From a research standpoint, exploring next-generation immunoassay platforms that integrate nanotechnology or microfluidics could enhance sensitivity and accuracy. Furthermore, strategic collaborations and partnerships with biotechnology firms can facilitate quicker technology integration and market expansion. The market is competitive, evolving, with robust demand for innovation to meet the growing needs of diverse healthcare settings. Therefore, focusing on technological breakthroughs and adaptive strategies can carve out significant market presence and business growth.

KEY MARKET STATISTICS
Base Year [2023] USD 12.15 billion
Estimated Year [2024] USD 12.72 billion
Forecast Year [2030] USD 19.43 billion
CAGR (%) 6.92%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Immunoassay Analyzers Market

The Immunoassay Analyzers Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High demand for use of immunoassays in oncology
    • Rising penetration of immunoassay-based point-of-care testing and rapid testing
    • Stringent regulation mandating drug and alcohol testing
  • Market Restraints
    • Unfavorable reimbursement policies
    • Stringent regulation for approvals
  • Market Opportunities
    • Constant development of immunoassay analyzers to diagnose microorganism-based infections
    • Integration of advanced technologies and product improvements
  • Market Challenges
    • False readings in immunoassay analyzers

Porter's Five Forces: A Strategic Tool for Navigating the Immunoassay Analyzers Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Immunoassay Analyzers Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Immunoassay Analyzers Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Immunoassay Analyzers Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Immunoassay Analyzers Market

A detailed market share analysis in the Immunoassay Analyzers Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Immunoassay Analyzers Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Immunoassay Analyzers Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Immunoassay Analyzers Market

A strategic analysis of the Immunoassay Analyzers Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Immunoassay Analyzers Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Boditech Med Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Merck KGaA, Ortho-Clinical Diagnostics, Inc., Quidel Corporation, Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc., and WAK-Chemie Medical GmbH.

Market Segmentation & Coverage

This research report categorizes the Immunoassay Analyzers Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Chemiluminescence Immunoassay, Consumables & Accessories, Enzyme-linked Immunoassay, Immunofluorescence Analyzers, and Radioimmunoassay.
  • Based on Application, market is studied across Autoimmune Disease, Cardiology, Endocrinology, Infectious Disease Testing, Oncology, and Therapeutic Drug Monitoring.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High demand for use of immunoassays in oncology
      • 5.1.1.2. Rising penetration of immunoassay-based point-of-care testing and rapid testing
      • 5.1.1.3. Stringent regulation mandating drug and alcohol testing
    • 5.1.2. Restraints
      • 5.1.2.1. Unfavorable reimbursement policies
      • 5.1.2.2. Stringent regulation for approvals
    • 5.1.3. Opportunities
      • 5.1.3.1. Constant development of immunoassay analyzers to diagnose microorganism-based infections
      • 5.1.3.2. Integration of advanced technologies and product improvements
    • 5.1.4. Challenges
      • 5.1.4.1. False readings in immunoassay analyzers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Immunoassay Analyzers Market, by Product

  • 6.1. Introduction
  • 6.2. Chemiluminescence Immunoassay
  • 6.3. Consumables & Accessories
  • 6.4. Enzyme-linked Immunoassay
  • 6.5. Immunofluorescence Analyzers
  • 6.6. Radioimmunoassay

7. Immunoassay Analyzers Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Disease
  • 7.3. Cardiology
  • 7.4. Endocrinology
  • 7.5. Infectious Disease Testing
  • 7.6. Oncology
  • 7.7. Therapeutic Drug Monitoring

8. Americas Immunoassay Analyzers Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Immunoassay Analyzers Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Immunoassay Analyzers Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Beckman Coulter, Inc.
  • 3. Becton Dickinson and Company
  • 4. Bio-Rad Laboratories, Inc.
  • 5. bioMerieux SA
  • 6. Boditech Med Inc.
  • 7. DiaSorin S.p.A.
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Merck KGaA
  • 10. Ortho-Clinical Diagnostics, Inc.
  • 11. Quidel Corporation
  • 12. Siemens Healthineers AG
  • 13. Sysmex Corporation
  • 14. Thermo Fisher Scientific Inc.
  • 15. WAK-Chemie Medical GmbH

LIST OF FIGURES

  • FIGURE 1. IMMUNOASSAY ANALYZERS MARKET RESEARCH PROCESS
  • FIGURE 2. IMMUNOASSAY ANALYZERS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IMMUNOASSAY ANALYZERS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IMMUNOASSAY ANALYZERS MARKET DYNAMICS
  • TABLE 7. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CHEMILUMINESCENCE IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CONSUMABLES & ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENZYME-LINKED IMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY IMMUNOFLUORESCENCE ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY RADIOIMMUNOASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY AUTOIMMUNE DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY INFECTIOUS DISEASE TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL IMMUNOASSAY ANALYZERS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AUSTRALIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. CHINA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. INDIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. INDONESIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. JAPAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MALAYSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. PHILIPPINES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. SINGAPORE IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. SOUTH KOREA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. TAIWAN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. THAILAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. VIETNAM IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. DENMARK IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. EGYPT IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. FINLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. FRANCE IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. GERMANY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. ISRAEL IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ITALY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. NETHERLANDS IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. NIGERIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. NORWAY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. POLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. QATAR IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. RUSSIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. SAUDI ARABIA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH AFRICA IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. SPAIN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. SWEDEN IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. SWITZERLAND IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. TURKEY IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM IMMUNOASSAY ANALYZERS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. UNITED KINGDOM IMMUNOASSAY ANALYZERS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. IMMUNOASSAY ANALYZERS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 107. IMMUNOASSAY ANALYZERS MARKET, FPNV POSITIONING MATRIX, 2023